Inoviem Scientific

Inoviem Scientific Raises €750k From Existing Financial Partners

Funding allows the company to broaden its range of services and finance its move to new laboratory facilities with five times more space in...
Pharmaceutical

California Presses Forward In Fight To Regulate Pharmaceutical Companies

In November, California voters defeated a ballot proposal that would have given state government more control over drug prices. It was a victory for pharmaceutical companies, which spent...
Glenmark

Glenmark Gets USFDA Nod For Anti-Cholesterol Drug

Drug firm Glenmark Pharmaceuticals today said it has received final approval from the USFDA for its generic version of Fenofibrate capsules used for lowering...
abbott

Abbott’s Stent Faces Another Storm, This Time On Safety

Even as healthcare major Abbott's bio-absorable stent ‘Absorb' battles price control challenges in India, another storm seems to be blowing in from Europe. The healthcare...
health coverage

Death By 1,000 Cuts: How Republicans Can Still Alter Your Health Coverage

The Affordable Care Act’s worst enemies are now in charge of the vast range of health coverage it created. They’re also discussing changes that could...
ATUM

ATUM Launches Cell-Line Development Service

Newark, USA, 10th April 2017 / ATUM (formerly DNA2.0) has announced an expansion of its services to include cell line development, which has been enabled...
abbott i-STAT

Abbott Strengthens Point-Of-Care Biz With Portable i-STAT

About three years ago, the Defence Research and Development Organsiation (DRDO) sourced a couple of hand-held i-STAT devices to check the blood parameters of...
Healthcare At Home India

Quadria Capital To Invest $40 mn In Healthcare At Home India

Noida-based home healthcare services provider Health Care At Home India Pvt Ltd will raise $40 million (Rs 250 crore) from healthcare-focused private equity firm...
Ocrevus

USFDA Approved Ocrevus To Treat Multiple Sclerosis

THERAPEUTIC ADVANCE The United States Food and Drug Administration has approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and...
Glenmark Pharmaceuticals

Glenmark Gets USFDA Nod For Milnacipran Hydrochloride Tablets

Glenmark Pharmaceuticals has received tentative approval from the USFDA for Milnacipran Hydrochloride tablets. “Glenmark Pharmaceuticals Inc, USA, has been granted tentative approval by the United...
Skip to toolbar